Percutaneous transluminal stenting for superior vena cava syndrome caused by malignant tumors: a single-center retrospective study.
Percutaneous transluminal stenting for superior vena cava syndrome caused by malignant tumors: a single-center retrospective study.
复制标题
DOI：
10.1186/s13019-021-01418-w
复制
发表时间：
2021-03-20
影响因子：
1.6
通讯作者：
Han X
中科院分区：
文献类型：
--
作者：
Liu H;Li Y;Wang Y;Yan L;Zhou P;Han X
评价经皮支架置入术治疗恶性肿瘤所致上级腔静脉综合征的疗效。我们回顾性分析了我科2015年至2019年因恶性肿瘤行经皮腔内支架治疗的32例上级腔静脉综合征患者的临床资料，总结了患者的性别、年龄、肿瘤类型、腔内治疗方案、并发症及术后随访情况。所有患者均在数字减影血管造影（DSA）下成功进行了经皮腔内支架置入术。32例患者共植入37枚血管内支架，其中Eluminexx支架21枚，Wallstent支架12枚，覆膜支架4枚。技术成功率为100%，无严重手术相关并发症。临床症状缓解率24 h为53.1%（17/32），48 h为84.4%（27/32）。其余患者48 h后症状缓慢缓解，7 d时症状缓解率为100%。随访1.5 ~ 24个月，平均随访6.5个月。随访期间，3例患者发生再狭窄，1例患者发生支架内继发血栓形成。第二次治疗后症状缓解。对于恶性肿瘤引起的上级腔静脉综合征，经皮腔内支架治疗能快速有效地缓解患者的临床症状，并发症发生率低。
To evaluate the efficacy of percutaneous stent placement in the treatment of superior vena cava syndrome caused by malignant tumors. We retrospectively analyzed the clinical data of 32 patients with superior vena cava syndrome who underwent percutaneous endovascular stent treatment in our department from 2015 to 2019 due to malignant tumors and summarized the patient’s sex, age, tumor type, endovascular treatment plan, complications and postoperative follow-up. All patients successfully underwent percutaneous intraluminal stent placement with digital subtraction angiography (DSA). Thirty-seven endovascular stents were implanted in 32 patients, including 21 Eluminexx stents, 12 Wallstent stents and 4 covered stents. The technical success rate was 100%, and there were no serious surgery-related complications. The remission rate of clinical symptoms was 53.1% (17/32) at 24 h and 84.4% (27/32) at 48 h. After 48 h, the symptoms of the remaining patients were slowly relieved, and the symptom relief rate was 100% at 7 days. The follow-up period was 1.5–24 months, with an average follow-up period of 6.5 months. During the follow-up, 3 patients had restenosis and 1 patient had secondary thrombosis in the stent. Their symptoms were relieved after the second treatment. For superior vena cava syndrome caused by malignant tumors, percutaneous endoluminal stent therapy can quickly and effectively relieve the clinical symptoms of patients, and the incidence of complications is low.
登录
查看更多内容
影响因子：
8.9
作者：
Niu, Su;Xu, Yuan-Shun;Cao, Chi
通讯作者：
Cao, Chi
影响因子：
2.9
作者：
Fagedet, Dorothee;Thony, Frederic;Moro-Sibilot, Denis
通讯作者：
Moro-Sibilot, Denis
影响因子：
5
作者：
Maleux, Geert;Gillardin, Patrick;Nackaerts, Kristiaan
通讯作者：
Nackaerts, Kristiaan
影响因子：
3.1
作者：
Kalra, Manju;Sen, Indrani;Gloviczki, Peter
通讯作者：
Gloviczki, Peter
影响因子：
5
作者：
Lanciego, C;Chacón, JL;García-García, L
通讯作者：
García-García, L